Pfizer asks FDA to approve COVID-19 vaccine boosters for ages 5-11
NEW YORK (WISH) — Pfizer is seeking emergency use authorization from the U.S. Food and Drug Administration for a second COVID-19 booster dose for ages 5 to 11.
The pharmaceutical company says a study showed a third vaccine dose raised omicron-fighting antibodies by 36 times in this age group. A total of 140 children were included in the study.
The first two doses of Pfizer’s vaccine were authorized for kids age 5 to 11 in October.
News at your fingertips! Stay informed with Indiana, Local, and National News straight to your inbox.